A new study reveals that cancer patients diagnosed during the early COVID-19 pandemic had worse short-term survival rates than a similar group before the pandemic. Published by the medical journal ...
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in healthy adult participants, met all its primary endpoints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results